Clinical Trials Logo

Filter by:
NCT ID: NCT04008043 Withdrawn - Oral Surgery Clinical Trials

Pilot Study: Effect of Dexamethasone vs Vicodin in Reducing Post-operative Pain

Start date: February 2020
Phase: Phase 4
Study type: Interventional

The main objective of the pilot study is to investigate the process that includes recruitment (to estimate the rate of enrollment), feasibility, protocol refinement, and willingness of the subject to be randomized. To provide a sample estimate of the population parameter which is the true value in the target population to be used in the planning of a larger confirmatory study. Secondary objectives include: To examine the efficacy of pre/post-operational administration of dexamethasone vs Vicodin (acetaminophen and hydrocodone) for post-operative pain control following periodontal surgery at the Henry M. Goldman School of Dental Medicine. To examine how BMI alters the response to dexamethasone and hydrocodone following periodontal surgery since obese patients have shown higher pain scores and increased pain sensitivity in previous experimental models of pain.

NCT ID: NCT04007588 Withdrawn - Melanoma Stage IV Clinical Trials

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Start date: September 6, 2019
Phase: Phase 2
Study type: Interventional

This research study is studying different immunotherapy regimens as a possible treatment for stage III or IV resectable melanoma.

NCT ID: NCT04006691 Withdrawn - Carcinoma Clinical Trials

Efficacy and Safety of UGN-101 in Recurrent Patients

Retreatment
Start date: October 1, 2019
Phase: Phase 3
Study type: Interventional

This trial is designed to evaluate the efficacy and safety of UGN-101 administered to the upper urinary tract (UUT) in patients who were treated in Trial TC-UT-03, found to be a complete response (CR) at the Primary Disease Evaluation (PDE) 1 Visit and are subsequently found to have a documented recurrence of low grade (LG) upper tract urothelial carcinoma (UTUC) at follow up (FU).

NCT ID: NCT04005209 Withdrawn - Acute Pain Clinical Trials

Ketamine Infusion for Sickle Cell Pain Crisis

Start date: January 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to prospectively study the efficacy of low dose ketamine infusions in treating patients who are admitted to the hospital with a sickle cell pain crisis. Participants will be prospectively randomized in unblinded fashion in the first 12 to 24 hours of an inpatient admission for sickle cell pain crisis to receive pain management without ketamine infusion (Group A) versus pain management that includes low-dose ketamine infusion starting at 0.2mg/kg/h (Group B). The effect of this intervention on various pain management and healthcare utilization outcome measures will be recorded and analyzed to determine whether or not there is a measurable benefit of using ketamine infusions in this patient population.

NCT ID: NCT04005079 Withdrawn - Ocular Hypertension Clinical Trials

Pilocarpine After Combined Cataract/Trabectome Surgery

PACCT
Start date: June 5, 2019
Phase: Phase 3
Study type: Interventional

Combined cataract + trabectome surgery is a surgery designed to help lower the intraocular pressure (pressure in the eye) and hopefully reduce the need for topical drops, progression of glaucoma, and/or further glaucoma surgeries. The purpose of this study is to assess whether using pilocarpine, a medication which is FDA approved to induce miosis, (in other words cause the pupil to constrict or become smaller) provides additional benefit to the success of Trabectome and cataract surgery.

NCT ID: NCT04001413 Withdrawn - Oropharynx Cancer Clinical Trials

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Start date: September 17, 2019
Phase: Phase 2
Study type: Interventional

Combination immune checkpoint inhibitor and DNA vaccine will result in clearance of HPV DNA biomarkers (oral and/or plasma) for patients with persistent HPV-16 E6/E7 DNA (HPV biomarker) after treatment with curative intent.

NCT ID: NCT04001101 Withdrawn - Colorectal Cancer Clinical Trials

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Start date: October 10, 2019
Phase: Phase 2
Study type: Interventional

To determine if the out-of-field ORR is improved with the addition of radiation therapy to anti-PD-1 for patients with MSI-H/dMMR metastatic solid tumors. Determine the rates of in-field tumor control, disease control (stable disease, partial response, complete response), durability of disease response, progression-free survival, overall survival, and to assess quality of life and toxicity. Determine the chronology and profile of the radiation-associated immune response.

NCT ID: NCT04000191 Withdrawn - Anesthesia, Local Clinical Trials

Ice as an Adjunct for Local Anesthesia During Anorectal Surgeries

Start date: October 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine, among patients receiving elective anorectal surgery, does application of ice to the perianal area prior to the procedure, lead to use of decreased amounts of intravenous (IV) anesthesia? Anorectal surgeries for hemorrhoids, fistulas and fissures are done on an outpatient basis under monitored anesthesia care. This means patients get sedating medications through an IV but often do not require intubation. The difficulty with monitored anesthesia is balancing patient comfort against the risk of apnea (not breathing due to over sedation). Application of ice to the perianal area may help increase patient comfort, decrease the amounts of medications given for sedation and therefore decrease risk and increase recovery from the anesthesia.

NCT ID: NCT03999216 Withdrawn - Heart Failure Clinical Trials

Comparing Diuretic Strategies in Hospitalized Heart Failure

Start date: July 2023
Phase: Phase 4
Study type: Interventional

We will conduct a pragmatic randomized trial comparing whether using a combination of two types of diuretics (loop + thiazide) compared with using a single diuretic (loop only) will result in shorter hospital stays for patients hospitalized with heart failure.

NCT ID: NCT03999190 Withdrawn - Schizophrenia Clinical Trials

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

Start date: July 2019
Phase:
Study type: Observational

The goals of this study is to determine (1) if differences in D2/3 receptor affinity states exist between medication-free subjects with SCH (MF-S) compared with healthy controls (HC), (2) the degree to which pre- and post-synaptic factors contribute to increased striatal dopamine (DA) signaling in MF-S and (3) to test the hypotheses that optimal DA transmission in the dorsal caudate (DCA) is necessary for normal working memory (WM) function.